COPENHAGEN, March 31 (Reuters) – Novo Nordisk Pharmatech, part of the Novo Nordisk NOVOb.CO group, has purchased a 47,000 square meter site in Koge, Denmark, with the aim of expanding its production, the company said on Friday.

Novo Nordisk Pharmatech supplies raw materials to Novo Nordisk’s pharmaceutical production, and to the wider pharmaceutical and biopharmaceutical industry.

(Reporting by Louise Breusch Rasmussen, editing by Terje Solsvik)

((Louisebreusch.rasmussen@tr.com; +45 21 27 97 79;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.